TGFB1 and neoplasm: For example, human Wharton’s jelly MSC-Exos (hWJ-MSC-Exos) limited liver failure (LF) and protected hepatocytes by inhibiting epithelial-tumor mesenchymal transition and inactivating the TGFβ1/SMAD2 pathway [243].